Ligand validation:1E7G

MYR: MYRISTIC ACID

MYR is a Ligand Of Interest in 1E7G designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1E7G_MYR_A_1004	63%	55%	0.11	0.937	0.77	0.97	-	1	0	0	81%	0.8125
1E7G_MYR_A_1005	55%	58%	0.133	0.901	0.69	0.91	-	1	1	0	100%	1
1E7G_MYR_A_1003	42%	53%	0.174	0.926	0.73	1.06	-	1	1	0	81%	0.8125
1E7G_MYR_A_1001	39%	55%	0.154	0.882	0.7	1.01	-	1	3	0	88%	0.875
1E7G_MYR_A_1002	27%	56%	0.234	0.882	0.65	1.05	-	1	3	0	100%	1
1E7G_MYR_A_1007	27%	77%	0.166	0.855	0.28	0.63	-	-	1	0	75%	0.75
1E7G_MYR_A_1006	5%	56%	0.319	0.74	0.63	1.04	-	1	0	0	100%	1
1E7G_MYR_A_1008	4%	74%	0.282	0.724	0.46	0.55	-	-	6	0	63%	0.625
4L8U_MYR_A_602	77%	60%	0.116	0.957	0.58	0.95	-	2	1	0	100%	1
3UIV_MYR_H_1003	71%	53%	0.096	0.951	0.64	1.15	-	1	0	0	81%	0.8125
2BXL_MYR_A_1005	65%	58%	0.13	0.931	0.64	0.97	-	1	1	0	100%	1
3SQJ_MYR_A_1006	62%	54%	0.133	0.926	0.54	1.21	-	2	1	0	100%	1
4LB9_MYR_A_602	61%	60%	0.169	0.958	0.59	0.94	-	1	2	0	100%	1
8Q2Z_MYR_C_201	93%	68%	0.081	0.975	0.46	0.77	-	-	0	0	100%	0.9375
6NOK_MYR_A_401	92%	52%	0.077	0.967	0.71	1.14	-	2	0	0	100%	1
8Q3D_MYR_D_101	92%	65%	0.086	0.975	0.53	0.81	-	-	0	0	100%	0.9375
7OWO_MYR_D_401	88%	73%	0.088	0.962	0.45	0.59	-	-	0	0	100%	0.525
8Q3T_MYR_C_201	87%	69%	0.092	0.965	0.47	0.72	-	-	0	0	100%	0.9375

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.